Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna’s Regenxbio RGNX Stock Holding History

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,000	Closed	-$80.8K	–	177
2024 Q1	$80.8K	Hold	4,000	–	–	0.03%	137
2023 Q4	$71.8K	Hold	4,000	–	–	0.03%	145
2023 Q3	$65.8K	Buy	4,000 +2,500	+167%	+$45.3K	0.04%	135
2023 Q2	$30K	Hold	1,500	–	–	0.01%	116
2023 Q1	$27.1K	Hold	1,500	–	–	0.02%	101
2022 Q4	$34K	Sell	1,500 -3,000	-67%	-$67.8K	0.03%	84
2022 Q3	$119K	Hold	4,500	–	–	0.1%	56
2022 Q2	$111K	Hold	4,500	–	–	0.07%	62
2022 Q1	$149K	Hold	4,500	–	–	0.07%	62
2021 Q4	$146K	Buy	4,500 +500	+13%	+$17K	0.04%	61
2021 Q3	$168K	Buy	+4,000	New	+$144K	0.04%	58

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IHAM

Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna's RGNX Position: Q2 2024 in Review

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna sold out of Regenxbio (RGNX) in Q2 2024, closing a stake of 4,000 shares — an estimated $80.8K sold.

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna first reported a position in RGNX in Q3 2021 and held it in 11 quarters. The position peaked at $168K in Q3 2021. 181 funds tracked by Wall St. Rank hold RGNX as of Q2 2024.

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna reported no remaining Regenxbio position as of Q2 2024 after selling out during the quarter.
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna sold 4,000 Regenxbio shares in Q2 2024, an estimated $80.8K.
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna first reported a position in Regenxbio in Q3 2021 and held it in 11 quarters.
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna's Regenxbio position peaked at $168K in Q3 2021.
181 funds tracked by Wall St. Rank held Regenxbio as of Q2 2024.

Based on Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna's 13F filing for Q2 2024, filed 29 Aug 2025.